Related Experiment Video
Updated: May 6, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state
Robert J Rounbehler1, Mohammad Fallahi, Chunying Yang
1Department of Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, USA.
Abstract:
Myc oncoproteins directly regulate transcription by binding to target genes, yet this only explains a fraction of the genes affected by Myc. mRNA turnover is controlled via AU-binding proteins (AUBPs) that recognize AU-rich elements (AREs) found within many transcripts. Analyses of precancerous and malignant Myc-expressing B cells revealed that Myc regulates hundreds of ARE-containing (ARED) genes and select AUBPs. Notably, Myc directly suppresses transcription of Tristetraprolin (TTP/ZFP36), an mRNA-destabilizing AUBP, and this circuit is also operational during B lymphopoiesis and IL7 signaling. Importantly, TTP suppression is a hallmark of cancers with MYC involvement, and restoring TTP impairs Myc-induced lymphomagenesis and abolishes maintenance of the malignant state. Further, there is a selection for TTP loss in malignancy; thus, TTP functions as a tumor suppressor. Finally, Myc/TTP-directed control of select cancer-associated ARED genes is disabled during lymphomagenesis. Thus, Myc targets AUBPs to regulate ARED genes that control tumorigenesis.
Insights
Myc oncoprotein affects gene expression by regulating mRNA turnover through AU-binding proteins (AUBPs). Suppressing Tristetraprolin (TTP) is key to Myc-driven cancers, with TTP acting as a tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Myc oncoproteins influence gene transcription, but a significant portion of Myc-regulated genes involves post-transcriptional mechanisms.
- mRNA turnover is modulated by AU-binding proteins (AUBPs) that interact with AU-rich elements (AREs) in transcripts.
- Understanding Myc's impact on AUBPs and ARE-containing (ARED) genes is crucial for deciphering its role in tumorigenesis.
Purpose of the Study:
- To investigate how Myc oncoproteins regulate mRNA turnover via AUBPs and ARED genes.
- To determine the role of Tristetraprolin (TTP/ZFP36), an AUBP, in Myc-driven lymphomagenesis.
- To elucidate the mechanism by which Myc influences TTP expression and its consequences in cancer.
Main Methods:
- Analysis of precancerous and malignant Myc-expressing B cells.
- Assessment of Myc's direct transcriptional regulation of TTP and other ARED genes.
- Evaluation of TTP's function in Myc-induced lymphomagenesis and cancer maintenance.
Main Results:
- Myc regulates hundreds of ARED genes and specific AUBPs in B cells.
- Myc directly suppresses the transcription of the mRNA-destabilizing AUBP, Tristetraprolin (TTP).
- TTP suppression is a hallmark of MYC-involved cancers, and its restoration inhibits lymphomagenesis, indicating TTP acts as a tumor suppressor.
Conclusions:
- Myc utilizes AUBPs, particularly TTP, to control ARED genes involved in tumorigenesis.
- The suppression of TTP by Myc is a critical circuit in B lymphopoiesis and IL7 signaling, and its dysregulation is selected for in malignancy.
- Targeting the Myc-TTP axis offers potential therapeutic strategies for MYC-driven cancers.
More Related Videos
Related Concept Videos
Drugs that Stabilize Microtubules
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic...

